Recently diagnosed with HIV? Click here

Ritonavir

Displayed below is content from the NAPWA website tagged with the keyword ritonavir.

Drugs linked to heart risks, minimal

Positive Living article • Adrian Ogier • 26 May 2011

A Canadian study has associated abacavir, efavirenz, lopinavir and ritonavir with an increased risk of heart attackA life-threatening emergency in which the blood supply to the heart is suddenly cut off, causing the heart muscle (myocardium) to die from lack of oxygen.. The research also showed that patients with HIV had twice the risk of heart attack compared to matched HIV
negative controls. read more »

Saquinavir warning

Positive Living article • Adrian Ogier • 2 December 2010

The US Food and Drug AdministrationThe U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness(Of a drug or treatment). The maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the standard procedure, Phase II clinical trials gauge efficacy, and Phase III trials confirm it. of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDAThe U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation's blood supply. The Australian equivalent is the Therapeutic Goods Administration (TGA). also works with the blood banking industry to safeguard the nation's blood supply. The Australian equivalent is the Therapeutic Goods Administration (TGA[Therapeutic Goods Administration] The federal government body that approves drugs and treatments before they can be prescribed.). and the European Medicines Agency have strengthened their warnings to doctors and patients about the potential of the HIV protease inhibitorA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate. saquinavir (Invirase) to cause disturbances in electrical activity in the heart leading to abnormal heart rhythm when the drug is combined with a boosting dose of ritonavir (Norvir). read more »

HAART on the heart

Positive Living article • Adrian Ogier • 5 June 2009

Starting Highly Active AntiretroviralA medication or other substance which is active against retroviruses such as HIV. Therapy can improve some of the things that lead to heart problems but not all of them, a recent study has revealed. Arteries which are already thickened or hardened do not improve on treatment. Metabolic complications, including increases in blood levels of lipids, are common in people on treatment and can also contribute to this condition. read more »

Treatment news from CROI

Positive Living article • John Daye • 13 March 2009

John Daye reports on treatments developments from the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in MontrĂ©al, Canada. read more »

Much more than a junket

Positive Living article • Paul Kidd • 13 October 2005

A report from the 3rd IAS Conference on HIV Pathogenesis and Treatment, held in Rio de Janiero in July. read more »

News and treatments briefs

Positive Living article • Paul Kidd • 15 February 2004
Positive women

HIV-related news in brief from the Feb-Mar 2004 edition of Positive Livingread more »

The power of one

Positive Living article • Paul Kidd • 15 December 2003

We all want simpler treatment regimens with fewer side effects and no meal restrictions, right? Well how does once-a-day treatment sound? As PAUL KIDD reports, it may be closer than you think. read more »

Syndicate content
Text size: font smallerfont normalfont larger

Stay in touch

NAPWA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWA's work and be alerted to new content on the website by following @napwa.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.